iCureCeliac® News

Researchers are collecting blood samples to learn more about the antigens that cause certain T cells to trigger intestinal damage in celiac disease patients. Complete a 30-minute study from home & be compensated $50 for your time.

At the Digestive Disease Week meeting in San Diego, researchers from Takeda and the Celiac Disease Foundation presented a study entitled, Adherence to the gluten-free diet and celiac patients outcomes: real world evidences from an international patient registry, iCureCeliac®. 

Researchers analyzed iCureCeliac® patient registry data to determine the effect of celiac disease-related depression on patients’ symptomatic response to a gluten-free diet.

The CeliacShield Study is being conducted to assess the investigational drug latiglutenase and its ability to protect the small intestine of celiac disease patients from gluten exposure.

If you have celiac disease and currently have kidney stones, or have had kidney stones in the past, you may be eligible for a new clinical research study!